Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission
M. Ryan Corces(Gladstone Institutes), Ravindra Majeti(Stanford University), Bruno C. Medeiros(Stanford Medicine), Wan‐Jen Hong, Irving L. Weissman(California Institute for Regenerative Medicine)
Cited by 701
Related Papers
Stem cells, cancer, and cancer stem cells
|Nature|2001|9.7k
An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues
|Nature Methods|2017|2.8k
Epigenetic memory in induced pluripotent stem cells
|Nature|2010|2.3k
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
|Nature|2017|2.3k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k